Amanullah Ashraf 4
4 · aTYR PHARMA INC · Filed Jun 7, 2018
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Amanullah Ashraf
Vice President, Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2018-05-31+3,333→ 26,264 total - Exercise/Conversion
Restricted Stock Units
2018-05-31+3,333→ 3,333 totalExercise: $0.00→ Common Stock (3,333 underlying)
Footnotes (3)
- [F1]Represent shares acquired upon vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017.
- [F2]Includes 2,500, 2,500, 2,499 and 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on November 15, 2016, May 15, 2017, November 15, 2017, and May 15, 2018, respectively, each in a transaction exempt under Rule 16b-3.
- [F3]The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the the grant commencing of February 7, 2018. Vesting was accelerated to May 31, 2018 pursuant to the Company's Executive Severance and Change In Control Policy.